Investigating long-term vascular complications after radiation in head and neck cancer patients
Official title: The Ambidirectional Cohort Study of Neurovascular Complications After Radiation Therapy in Head and Neck Cancer Patients
Run by Chang Gung Memorial Hospital · NCT06111430 · Data updated 2026-11-12
This study looks at how radiation treatment affects blood vessel health over time in people with head and neck cancer, comparing those with nasopharyngeal cancer to others.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 100 Years |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | April 11, 2022 |
| Main results expected | April 10, 2023 |
| Study ends | April 10, 2027 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT06111430 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 20 and older who have been diagnosed with head and neck cancer and have received radiation therapy within the last 72 months or more than 120 months ago.
✕Probably not a fit
Patients under 20 years of age or those unwilling to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the prevalence of cervical-cranial vascular complications in patients with head and neck cancer who have received radiation therapy. It will compare outcomes between patients with nasopharyngeal cancer and those with other types of head and neck cancers. Participants will be recruited based on their history of radiation treatment and will undergo brain imaging and vascular studies to evaluate complications. The study focuses on both early and long-term effects of radiation therapy on vascular health.
Why it matters
Potential benefit: If successful, this study could improve understanding of long-term vascular risks in head and neck cancer patients, leading to better monitoring and management strategies.
How similar studies have gone: While there is ongoing research into the effects of radiation therapy on vascular health, this specific focus on long-term complications in head and neck cancer patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Population: Prospective cohort Inclusion Criteria: 1. Age ≥20 years. 2. Head and neck cancer patient . 3. Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry. 4. Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment. Exclusion Criteria: 1. Age \<20 years. 2. Patients not willing to sign the informed consent. Population: Retrospective validation cohort Inclusion Criteria: 1. Age ≥20 years. 2. Head and neck cancer patient. 3. Had ever received radiation therapy (RT) \> 120 months before the adoption date of IRB at the participant site. 4. Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6\~10 years after RT, one within 5 years after RT, the other after 5 years after RT. Exclusion Criteria: 1.Age \<20 years.
Where it's running
-
Chang Gung Memorial Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Chi-Hung Liu
- Email: ivanliu001@cgmh.org.tw
- Phone: (03)3281200
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Silverlon for head and neck patients with tracheostomies
This early-phase study tests whether Silverlon dressings can prevent severe skin reactions under tracheostomy collars in adults with head and neck cancer.
-
Registry of patients treated with proton beam therapy
This study is creating a database of patients treated with proton beam therapy for cancer to see how well it works and how safe it is.
-
Targeted high- and low-dose radiation with chemotherapy and immunotherapy for advanced lung cancer
This trial tests whether adding focused high‑dose and low‑dose radiation to chemotherapy and immunotherapy helps people with advanced lung cancer whose disease progressed after prior immunotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.